Recently I added to my position in ABBV purchasing 6 shares for $541.26. The dividend is currently yielding over 5 percent and with a 48 percent payout ratio and a strong cash flow, the dividend appears relatively safe for now. I'm aware that they may lose market share to competitors, but that is always the case with drug companies. They appear to be in good position for now with their cancer and immunology drugs.
Disclosure Long: ABBV